LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways.

Lange, Ingo / Espinoza-Fuenzalida, Italo / Ali, Mourad Wagdy / Serrano, Laura Espana / Koomoa, Dana-Lynn T

Oncotarget

2017  Volume 8, Issue 66, Page(s) 109985–109999

Abstract: ... The results showed that FTY-720 regulates multiple pathways that result in various effects ... on calcium signaling, ion channel activation and cell survival/death pathways. FTY-720 rapidly inhibits TRPM7 channel ... the effects of FTY-720 or fingolimod, a drug that is FDA-approved for refractory multiple sclerosis, in NB ...

Abstract Neuroblastoma (NB) is the most common extra-cranial pediatric solid tumor. High-risk NB is difficult to treat due to the lack of response to current therapies and aggressive disease progression. Despite novel drugs, alternative treatments and multi-modal treatments, finding an effective treatment strategy for these patients continues to be a major challenge. The current study focuses on examining the effects of FTY-720 or fingolimod, a drug that is FDA-approved for refractory multiple sclerosis, in NB. The results showed that FTY-720 regulates multiple pathways that result in various effects on calcium signaling, ion channel activation and cell survival/death pathways. FTY-720 rapidly inhibits TRPM7 channel activity, and inhibited TRPM7 kinase activity, modulates calcium signaling, induces a loss of mitochondrial membrane potential and opening of the mitochondrial permeability transition pore, and ultimately leads to cell death. Interestingly, the data also showed that low concentrations of FTY-720 sensitized drug-resistant NB cells to antineoplastic drugs. These results suggest that FTY-720 may be an attractive alternative for the treatment of NB.
Language English
Publishing date 2017-12-15
Publishing country United States
Document type Journal Article
ZDB-ID 2560162-3
ISSN 1949-2553 ; 1949-2553
ISSN (online) 1949-2553
ISSN 1949-2553
DOI 10.18632/oncotarget.22452
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top